Novo Nordisk and Septerna Forge $2.2B+ Collaboration on Oral Obesity and Diabetes Drugs

Novo Nordisk; Septerna; GPCR; oral drugs; obesity; type 2 diabetes; cardiometabolic diseases; GLP-1; GIP; glucagon receptors; small molecule therapies; collaboration; pharmaceuticals

Terray Therapeutics and Gilead Sciences Collaborate on AI-Driven Drug Discovery to Accelerate Small Molecule Therapies

AI-driven drug discovery, Terray Therapeutics, Gilead Sciences, Small molecule therapies, tNova platform, High-throughput experimentation, Generative AI, Strategic collaboration